文献速递肺栓塞与肺血管病

Y染色体基因Uty通过减少促炎趋化因子对抗肺动脉高压

Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该研究在去势雄性小鼠缺氧模型中敲低肺内表达的Y染色体基因,发现敲低Uty导致更严重的肺动脉高压,并上调促炎趋化因子Cxcl9和Cxcl10;人PAH肺组织中CXCL9和CXCL10显著上调且女性更明显;抑制这些趋化因子可减轻多种实验模型的PH严重程度。

要点

  • 敲低Y染色体基因Uty加重缺氧诱导的小鼠肺动脉高压。
  • Uty敲低上调促炎趋化因子Cxcl9和Cxcl10,触发内皮细胞凋亡。
  • 抑制CXCL9/CXCL10可减轻实验性肺动脉高压。

核心结论

  • Uty对肺动脉高压具有保护作用,其表达减少导致促炎趋化因子Cxcl9和Cxcl10增加,引发内皮细胞死亡和PH。
  • 抑制CXCL9和CXCL10可在多种实验模型中挽救PH发展。

研究设计与样本

  • 在去势雄性小鼠缺氧模型中,通过气管内滴注siRNA敲低肺内表达的每个Y染色体基因,监测右心室和肺动脉血流动力学变化。
  • 比较Uty敲低小鼠肺转录组与男性和女性PAH患者肺组织,鉴定共同下游致病趋化因子,并在人肺动脉内皮细胞测试其效应。
  • 在两种临床前肺动脉高压模型中抑制这些趋化因子活性以测试治疗效果。

主要发现

  • 敲低Uty导致右心室压力升高和肺动脉加速时间缩短,表明PH更严重。
  • RNA测序显示Uty敲低导致促炎趋化因子Cxcl9和Cxcl10增加。
  • 人PAH肺组织中CXCL9和CXCL10显著上调,女性PAH患者上调更明显。
  • CXCL9和CXCL10处理人肺动脉内皮细胞触发凋亡。
  • 在雄性Uty敲除小鼠中抑制Cxcl9和Cxcl10表达、在雌性大鼠中抑制CXCL9和CXCL10活性,均显著减轻PH严重程度。

临床怎么用

  • Uty表达减少和CXCL9/CXCL10升高可能作为PAH的潜在生物标志物或治疗靶点。
  • 抑制CXCL9/CXCL10为肺动脉高压提供了新的临床前治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Idiopathic pulmonary arterial hypertension (PAH) is a terminal pulmonary vascular disease characterized by increased pressure, right ventricular failure, and death. PAH exhibits a striking sex bias and is up to four times more prevalent in females. Understanding the molecular basis behind sex differences could help uncover novel therapies. Objectives: We previously discovered that the Y chromosome is protective against hypoxia-induced experimental pulmonary hypertension (PH), which may contribute to sex differences in PAH. Here, we identify the gene responsible for Y-chromosome protection, investigate key downstream autosomal genes, and demonstrate a novel preclinical therapy. Methods: To test the effect of Y-chromosome genes on PH development, we knocked down each Y-chromosome gene expressed in the lung by means of intratracheal instillation of siRNA in gonadectomized male mice exposed to hypoxia and monitored changes in right ventricular and pulmonary artery hemodynamics. We compared the lung transcriptome of Uty knockdown mouse lungs to those of male and female PAH patient lungs to identify common downstream pathogenic chemokines and tested the effects of these chemokines on human pulmonary artery endothelial cells. We further inhibited the activity of these chemokines in two preclinical pulmonary hypertension models to test the therapeutic efficacy. Measurements and Main Results: Knockdown of the Y-chromosome gene Uty resulted in more severe PH measured by increased right ventricular pressure and decreased pulmonary artery acceleration time. RNA sequencing revealed an increase in proinflammatory chemokines Cxcl9 and Cxcl10 as a result of Uty knockdown. We found CXCL9 and CXCL10 significantly upregulated in human PAH lungs, with more robust upregulation in females with PAH. Treatment of human pulmonary artery endothelial cells with CXCL9 and CXCL10 triggered apoptosis. Inhibition of Cxcl9 and Cxcl10 expression in male Uty knockout mice and CXCL9 and CXCL10 activity in female rats significantly reduced PH severity. Conclusions:Uty is protective against PH. Reduction of Uty expression results in increased expression of proinflammatory chemokines Cxcl9 and Cxcl10, which trigger endothelial cell death and PH. Inhibition of CLXC9 and CXLC10 rescues PH development in multiple experimental models.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Cunningham CM, Li M, Ruffenach G, et al. Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines. Am J Respir Crit Care Med. 2022. PMID: 35504005. doi:10.1164/rccm.202110-2309OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。